Understanding the Journey to Treatment
Receiving a Tuberous Sclerosis Complex (TSC) diagnosis can bring a mix of emotions. For some families, it provides answers after experiencing unexplained symptoms. For others, it raises new questions about treatment, long-term care, and next steps.
TSC is a rare genetic disorder that can affect multiple organ systems. Because every person experiences TSC differently, treatment plans and care needs vary widely. While the condition requires lifelong monitoring, advances in treatment and coordinated care have helped many patients achieve better health outcomes and improved quality of life.
Understanding the steps that follow a diagnosis can help patients and caregivers feel more prepared for the journey ahead.
After a TSC diagnosis, one of the most important priorities is establishing a coordinated care team.
Patients often require support from multiple specialists depending on how the condition presents. Without coordination, important information can become fragmented among providers, leading to treatment delays and unnecessary administrative burdens for families.
At Total Care RX, we apply The Total Care RX Equation™—a precision-driven approach designed to improve outcomes in complex and rare conditions. By identifying each patient's unique needs, aligning providers and caregivers around a unified treatment plan, accelerating access to therapy, and managing long-term continuity of care, we help transform complexity into coordinated action. Through persistent patient advocacy and proactive support, we guide patients and families from treatment initiation through every stage of their care journey.
Treatment for TSC is highly individualized and depends on the specific manifestations of the disease.
Common treatment approaches may include:
Because treatment needs can evolve over time, continuity of care and regular follow-up are essential.
For many patients, receiving a prescription is only the beginning of the treatment journey.
Accessing specialty medications often involves navigating:
Certain therapies used in TSC care, including the first FDA-approved treatment for TSC facial angiofibroma in patients six and older, HYFTOR (sirolimus topical gel 0.2%) developed by Nobelpharma America (NPA), are distributed only through limited specialty pharmacy networks, making access coordination especially important.
These administrative hurdles can create delays that impact the start of therapy and add stress for patients and caregivers already managing a complex condition.
Specialty pharmacies play a critical role in helping patients access and stay on therapy.
As a specialty pharmacy with expertise in rare and neurologic conditions, Total Care RX works proactively to remove barriers throughout the treatment journey. Our team helps:
Successful TSC treatment extends beyond medication fulfillment.
Patients and families often benefit from educational resources, advocacy organizations, support networks, and healthcare partners who understand the challenges of living with a rare disease.
That's why Total Care RX remains focused on providing precision-driven, patient-first care designed to support every stage of the treatment journey. We’re also proud to support the TSC community as a sponsor and attendee of the 2026 TSC World Conference, one of the largest global gatherings dedicated to advancing TSC diagnosis, treatment, research, and patient support.
Download the TSC Access Guide for Neurology & Field Teams to learn more about reducing delays and supporting faster access to therapy.